accession stringclasses 716
values | cik stringclasses 420
values | company stringclasses 422
values | ticker stringclasses 394
values | filed_date stringdate 2026-07-21 00:00:00 2026-10-19 00:00:00 ⌀ | form stringclasses 1
value | signal stringclasses 12
values | negative bool 2
classes | file_name stringclasses 691
values | url stringlengths 44 98 |
|---|---|---|---|---|---|---|---|---|---|
0001213900-26-107410 | 1870404 | CERO THERAPEUTICS HOLDINGS, INC. | null | 2026-10-07 | 8-K | clinical_hold | true | ea030773301ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1870404/000121390026107410/ea030773301ex10-1.htm |
0001437749-26-032107 | 1787740 | Valion Bio, Inc. | VBIO | 2026-10-06 | 8-K | fast_track | false | ex_1022416.htm | https://www.sec.gov/Archives/edgar/data/1787740/000143774926032107/ex_1022416.htm |
0001493152-26-045860 | 1971532 | Telomir Pharmaceuticals, Inc. | TELO | 2026-10-06 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1971532/000149315226045860/ex10-1.htm |
0001140361-26-038818 | 1281895 | ROCKET PHARMACEUTICALS, INC. | RCKT | 2026-10-06 | 8-K | clinical_hold | true | ef20083350_ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1281895/000114036126038818/ef20083350_ex10-1.htm |
0001140361-26-038818 | 1281895 | ROCKET PHARMACEUTICALS, INC. | RCKT | 2026-10-06 | 8-K | ind | false | ef20083350_ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1281895/000114036126038818/ef20083350_ex10-1.htm |
0001493152-26-045844 | 1962011 | Kairos Pharma, LTD. | KAPA | 2026-10-06 | 8-K | interim | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1962011/000149315226045844/ex99-1.htm |
0001104659-26-113898 | 1868279 | ArriVent BioPharma, Inc. | AVBP | 2026-10-06 | 8-K | endpoint_missed | true | tm2627092d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1868279/000110465926113898/tm2627092d1_ex99-1.htm |
0001104659-26-113898 | 1868279 | ArriVent BioPharma, Inc. | AVBP | 2026-10-06 | 8-K | breakthrough | false | tm2627092d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1868279/000110465926113898/tm2627092d1_ex99-1.htm |
0001104659-26-113898 | 1868279 | ArriVent BioPharma, Inc. | AVBP | 2026-10-06 | 8-K | orphan | false | tm2627092d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1868279/000110465926113898/tm2627092d1_ex99-1.htm |
0001213900-26-106979 | 1946563 | 60 DEGREES PHARMACEUTICALS, INC. | null | 2026-10-06 | 8-K | interim | false | ea030776101ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1946563/000121390026106979/ea030776101ex99-1.htm |
0001213900-26-106979 | 1946563 | 60 DEGREES PHARMACEUTICALS, INC. | null | 2026-10-06 | 8-K | pdufa | false | ea030776101ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1946563/000121390026106979/ea030776101ex99-1.htm |
0001193125-26-413168 | 1649094 | Vaxcyte, Inc. | PCVX | 2026-10-05 | 8-K | topline | false | d21202dex992.htm | https://www.sec.gov/Archives/edgar/data/1649094/000119312526413168/d21202dex992.htm |
0001193125-26-413168 | 1649094 | Vaxcyte, Inc. | PCVX | 2026-10-05 | 8-K | breakthrough | false | d21202dex991.htm | https://www.sec.gov/Archives/edgar/data/1649094/000119312526413168/d21202dex991.htm |
0001104659-26-113503 | 1509261 | Rezolute, Inc. | RZLT | 2026-10-05 | 8-K | topline | false | tm2626976d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1509261/000110465926113503/tm2626976d1_ex99-1.htm |
0001104659-26-113503 | 1509261 | Rezolute, Inc. | RZLT | 2026-10-05 | 8-K | endpoint_missed | true | tm2626976d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1509261/000110465926113503/tm2626976d1_ex99-1.htm |
0001140361-26-038535 | 1533743 | Processa Pharmaceuticals, Inc. | PCSA | 2026-10-05 | 8-K | topline | false | ef20083140_ex99-4.htm | https://www.sec.gov/Archives/edgar/data/1533743/000114036126038535/ef20083140_ex99-4.htm |
0001140361-26-038535 | 1533743 | Processa Pharmaceuticals, Inc. | PCSA | 2026-10-05 | 8-K | crl | true | ef20083140_ex99-3.htm | https://www.sec.gov/Archives/edgar/data/1533743/000114036126038535/ef20083140_ex99-3.htm |
0001140361-26-038535 | 1533743 | Processa Pharmaceuticals, Inc. | PCSA | 2026-10-05 | 8-K | clinical_hold | true | ef20083140_ex99-3.htm | https://www.sec.gov/Archives/edgar/data/1533743/000114036126038535/ef20083140_ex99-3.htm |
0001140361-26-038535 | 1533743 | Processa Pharmaceuticals, Inc. | PCSA | 2026-10-05 | 8-K | breakthrough | false | ef20083140_ex99-3.htm | https://www.sec.gov/Archives/edgar/data/1533743/000114036126038535/ef20083140_ex99-3.htm |
0001140361-26-038535 | 1533743 | Processa Pharmaceuticals, Inc. | PCSA | 2026-10-05 | 8-K | fast_track | false | ef20083140_ex99-3.htm | https://www.sec.gov/Archives/edgar/data/1533743/000114036126038535/ef20083140_ex99-3.htm |
0001140361-26-038535 | 1533743 | Processa Pharmaceuticals, Inc. | PCSA | 2026-10-05 | 8-K | pdufa | false | ef20083140_ex99-3.htm | https://www.sec.gov/Archives/edgar/data/1533743/000114036126038535/ef20083140_ex99-3.htm |
0001140361-26-038535 | 1533743 | Processa Pharmaceuticals, Inc. | PCSA | 2026-10-05 | 8-K | ind | false | ef20083140_ex99-3.htm | https://www.sec.gov/Archives/edgar/data/1533743/000114036126038535/ef20083140_ex99-3.htm |
0001140361-26-038535 | 1533743 | Processa Pharmaceuticals, Inc. | PCSA | 2026-10-05 | 8-K | discontinue | true | ef20083140_ex99-4.htm | https://www.sec.gov/Archives/edgar/data/1533743/000114036126038535/ef20083140_ex99-4.htm |
0001193125-26-413254 | 1699382 | PMV Pharmaceuticals, Inc. | PMVP | 2026-10-05 | 8-K | fast_track | false | d174662dex991.htm | https://www.sec.gov/Archives/edgar/data/1699382/000119312526413254/d174662dex991.htm |
0001193125-26-413254 | 1699382 | PMV Pharmaceuticals, Inc. | PMVP | 2026-10-05 | 8-K | orphan | false | d174662dex991.htm | https://www.sec.gov/Archives/edgar/data/1699382/000119312526413254/d174662dex991.htm |
0001213900-26-106849 | 1795091 | OS Therapies Inc | OSTX | 2026-10-05 | 8-K | fast_track | false | ea030761101ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1795091/000121390026106849/ea030761101ex99-1.htm |
0001213900-26-106849 | 1795091 | OS Therapies Inc | OSTX | 2026-10-05 | 8-K | orphan | false | ea030761101ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1795091/000121390026106849/ea030761101ex99-1.htm |
0001437749-26-032042 | 1719406 | NRX Pharmaceuticals, Inc. | NRXP | 2026-10-05 | 8-K | breakthrough | false | ex_1022189.htm | https://www.sec.gov/Archives/edgar/data/1719406/000143774926032042/ex_1022189.htm |
0001437749-26-032042 | 1719406 | NRX Pharmaceuticals, Inc. | NRXP | 2026-10-05 | 8-K | fast_track | false | ex_1022189.htm | https://www.sec.gov/Archives/edgar/data/1719406/000143774926032042/ex_1022189.htm |
0001104659-26-113763 | 1425205 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | 2026-10-05 | 8-K | interim | false | tm2627047d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1425205/000110465926113763/tm2627047d1_ex99-1.htm |
0001104659-26-113763 | 1425205 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | 2026-10-05 | 8-K | fast_track | false | tm2627047d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1425205/000110465926113763/tm2627047d1_ex99-1.htm |
0001104659-26-113763 | 1425205 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | 2026-10-05 | 8-K | ind | false | tm2627047d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1425205/000110465926113763/tm2627047d1_ex99-1.htm |
0001193125-26-413218 | 1835022 | Coya Therapeutics, Inc. | COYA | 2026-10-05 | 8-K | topline | false | d95167d8k.htm | https://www.sec.gov/Archives/edgar/data/1835022/000119312526413218/d95167d8k.htm |
0001193125-26-413218 | 1835022 | Coya Therapeutics, Inc. | COYA | 2026-10-05 | 8-K | fast_track | false | d95167d8k.htm | https://www.sec.gov/Archives/edgar/data/1835022/000119312526413218/d95167d8k.htm |
0001193125-26-413177 | 1808898 | Benitec Biopharma Inc. | BNTC | 2026-10-05 | 8-K | orphan | false | bntc-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1808898/000119312526413177/bntc-ex99_1.htm |
0001193125-26-411011 | 1789972 | Cullinan Therapeutics, Inc. | CGEM | 2026-10-02 | 8-K | endpoint_met | false | cgem-20261001.htm | https://www.sec.gov/Archives/edgar/data/1789972/000119312526411011/cgem-20261001.htm |
0001193125-26-411011 | 1789972 | Cullinan Therapeutics, Inc. | CGEM | 2026-10-02 | 8-K | breakthrough | false | cgem-20261001.htm | https://www.sec.gov/Archives/edgar/data/1789972/000119312526411011/cgem-20261001.htm |
0001193125-26-411011 | 1789972 | Cullinan Therapeutics, Inc. | CGEM | 2026-10-02 | 8-K | pdufa | false | cgem-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1789972/000119312526411011/cgem-ex99_1.htm |
0001104659-26-113055 | 1850119 | Century Therapeutics, Inc. | IPSC | 2026-10-02 | 8-K | ind | false | tm2626840d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1850119/000110465926113055/tm2626840d1_ex99-1.htm |
0001193125-26-411259 | 1095981 | CERENOME, INC. | CNSY | 2026-10-02 | 8-K | topline | false | cnsy-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1095981/000119312526411259/cnsy-ex99_1.htm |
0001193125-26-411259 | 1095981 | CERENOME, INC. | CNSY | 2026-10-02 | 8-K | interim | false | cnsy-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1095981/000119312526411259/cnsy-ex99_1.htm |
0001193125-26-412300 | 1709941 | BioAge Labs, Inc. | BIOA | 2026-10-02 | 8-K | topline | false | bioa-20261002.htm | https://www.sec.gov/Archives/edgar/data/1709941/000119312526412300/bioa-20261002.htm |
0001193125-26-409335 | 1400118 | Sagimet Biosciences Inc. | SGMT | 2026-10-01 | 8-K | topline | false | d136610d8k.htm | https://www.sec.gov/Archives/edgar/data/1400118/000119312526409335/d136610d8k.htm |
0001645113-26-000071 | 1645113 | NovoCure Ltd | NVCR | 2026-10-01 | 8-K | endpoint_met | false | paxjapandecisionpr.htm | https://www.sec.gov/Archives/edgar/data/1645113/000164511326000071/paxjapandecisionpr.htm |
0001213900-26-105453 | 906709 | NEKTAR THERAPEUTICS | NKTR | 2026-10-01 | 8-K | topline | false | ea030730601ex99-1.htm | https://www.sec.gov/Archives/edgar/data/906709/000121390026105453/ea030730601ex99-1.htm |
0001213900-26-105453 | 906709 | NEKTAR THERAPEUTICS | NKTR | 2026-10-01 | 8-K | fast_track | false | ea030730601ex99-1.htm | https://www.sec.gov/Archives/edgar/data/906709/000121390026105453/ea030730601ex99-1.htm |
0001493152-26-045260 | 1701478 | Azitra, Inc. | AZTR | 2026-10-01 | 8-K | topline | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1701478/000149315226045260/ex99-1.htm |
0001493152-26-045260 | 1701478 | Azitra, Inc. | AZTR | 2026-10-01 | 8-K | fast_track | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1701478/000149315226045260/ex99-1.htm |
0001193125-26-408224 | 1400118 | Sagimet Biosciences Inc. | SGMT | 2026-09-30 | 8-K | breakthrough | false | d96035dex991.htm | https://www.sec.gov/Archives/edgar/data/1400118/000119312526408224/d96035dex991.htm |
0001193125-26-408224 | 1400118 | Sagimet Biosciences Inc. | SGMT | 2026-09-30 | 8-K | ind | false | d96035dex991.htm | https://www.sec.gov/Archives/edgar/data/1400118/000119312526408224/d96035dex991.htm |
0001213900-26-104876 | 1713863 | Rafael Holdings, Inc. | RFL | 2026-09-30 | 8-K | topline | false | ea030712501ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1713863/000121390026104876/ea030712501ex99-1.htm |
0001104659-26-112340 | 872589 | REGENERON PHARMACEUTICALS, INC. | REGN | 2026-09-30 | 8-K | clinical_hold | true | tm2626090d1_ex10-1.htm | https://www.sec.gov/Archives/edgar/data/872589/000110465926112340/tm2626090d1_ex10-1.htm |
0001104659-26-112340 | 872589 | REGENERON PHARMACEUTICALS, INC. | REGN | 2026-09-30 | 8-K | ind | false | tm2626090d1_ex10-1.htm | https://www.sec.gov/Archives/edgar/data/872589/000110465926112340/tm2626090d1_ex10-1.htm |
0001193125-26-408435 | 1661998 | Q32 Bio Inc. | QTTB | 2026-09-30 | 8-K | topline | false | d13352d8k.htm | https://www.sec.gov/Archives/edgar/data/1661998/000119312526408435/d13352d8k.htm |
0001493152-26-045100 | 1763950 | Lantern Pharma Inc. | LTRN | 2026-09-30 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1763950/000149315226045100/ex10-1.htm |
0001493152-26-045143 | 1873835 | Immix Biopharma, Inc. | IMMX | 2026-09-30 | 8-K | breakthrough | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1873835/000149315226045143/ex99-1.htm |
0001493152-26-045143 | 1873835 | Immix Biopharma, Inc. | IMMX | 2026-09-30 | 8-K | orphan | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1873835/000149315226045143/ex99-1.htm |
0001193125-26-408052 | 1613780 | DBV Technologies S.A. | null | 2026-09-30 | 8-K | breakthrough | false | d118963dex991.htm | https://www.sec.gov/Archives/edgar/data/1613780/000119312526408052/d118963dex991.htm |
0001835268-26-000038 | 1835268 | Connect Biopharma Holdings Ltd | CNTB | 2026-09-30 | 8-K | topline | false | a991.htm | https://www.sec.gov/Archives/edgar/data/1835268/000183526826000038/a991.htm |
0001835268-26-000038 | 1835268 | Connect Biopharma Holdings Ltd | CNTB | 2026-09-30 | 8-K | interim | false | cntb-20260930.htm | https://www.sec.gov/Archives/edgar/data/1835268/000183526826000038/cntb-20260930.htm |
0000023217-26-000052 | 23217 | CONAGRA BRANDS INC. | CAG | 2026-09-30 | 8-K | topline | false | tmb-ex99d1.htm | https://www.sec.gov/Archives/edgar/data/23217/000002321726000052/tmb-ex99d1.htm |
0001193125-26-409169 | 1658678 | BioStem Technologies, Inc. | BSEM | 2026-09-30 | 8-K | clinical_hold | true | bsem-ex10_1.htm | https://www.sec.gov/Archives/edgar/data/1658678/000119312526409169/bsem-ex10_1.htm |
0001837607-26-000064 | 1837607 | AEON Biopharma, Inc. | AEON | 2026-09-30 | 8-K | ind | false | aeon-20260930x8k.htm | https://www.sec.gov/Archives/edgar/data/1837607/000183760726000064/aeon-20260930x8k.htm |
0001104659-26-111654 | 1590560 | uniQure N.V. | QURE | 2026-09-29 | 8-K | topline | false | tm2626514d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1590560/000110465926111654/tm2626514d1_ex99-2.htm |
0001104659-26-111654 | 1590560 | uniQure N.V. | QURE | 2026-09-29 | 8-K | breakthrough | false | tm2626514d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1590560/000110465926111654/tm2626514d1_ex99-2.htm |
0001104659-26-111654 | 1590560 | uniQure N.V. | QURE | 2026-09-29 | 8-K | fast_track | false | tm2626514d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1590560/000110465926111654/tm2626514d1_ex99-2.htm |
0001213900-26-104314 | 1766140 | Unicycive Therapeutics, Inc. | UNCY | 2026-09-29 | 8-K | crl | true | ea030696701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1766140/000121390026104314/ea030696701ex99-1.htm |
0001213900-26-104314 | 1766140 | Unicycive Therapeutics, Inc. | UNCY | 2026-09-29 | 8-K | orphan | false | ea030696701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1766140/000121390026104314/ea030696701ex99-1.htm |
0001213900-26-104314 | 1766140 | Unicycive Therapeutics, Inc. | UNCY | 2026-09-29 | 8-K | pdufa | false | ea030696701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1766140/000121390026104314/ea030696701ex99-1.htm |
0001193125-26-407823 | 1681087 | Tectonic Therapeutic, Inc. | TECX | 2026-09-29 | 8-K | topline | false | d20857dex991.htm | https://www.sec.gov/Archives/edgar/data/1681087/000119312526407823/d20857dex991.htm |
0001193125-26-407823 | 1681087 | Tectonic Therapeutic, Inc. | TECX | 2026-09-29 | 8-K | fast_track | false | d20857dex991.htm | https://www.sec.gov/Archives/edgar/data/1681087/000119312526407823/d20857dex991.htm |
0001193125-26-405776 | 1599298 | Summit Therapeutics Inc. | SMMT | 2026-09-29 | 8-K | clinical_hold | true | d178892dex101.htm | https://www.sec.gov/Archives/edgar/data/1599298/000119312526405776/d178892dex101.htm |
0001193125-26-405776 | 1599298 | Summit Therapeutics Inc. | SMMT | 2026-09-29 | 8-K | pdufa | false | d178892dex991.htm | https://www.sec.gov/Archives/edgar/data/1599298/000119312526405776/d178892dex991.htm |
0001193125-26-407696 | 1783183 | Phathom Pharmaceuticals, Inc. | PHAT | 2026-09-29 | 8-K | topline | false | d22070d8k.htm | https://www.sec.gov/Archives/edgar/data/1783183/000119312526407696/d22070d8k.htm |
0001129928-26-000059 | 1129928 | ONCOLYTICS BIOTECH INC | ONCY | 2026-09-29 | 8-K | fast_track | false | pnashccpublication.htm | https://www.sec.gov/Archives/edgar/data/1129928/000112992826000059/pnashccpublication.htm |
0001193125-26-406007 | 1832038 | Invivyd, Inc. | IVVD | 2026-09-29 | 8-K | topline | false | ivvd-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1832038/000119312526406007/ivvd-ex99_1.htm |
0001193125-26-406007 | 1832038 | Invivyd, Inc. | IVVD | 2026-09-29 | 8-K | fast_track | false | ivvd-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/1832038/000119312526406007/ivvd-ex99_2.htm |
0001493152-26-044761 | 1873835 | Immix Biopharma, Inc. | IMMX | 2026-09-29 | 8-K | breakthrough | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1873835/000149315226044761/ex99-1.htm |
0001493152-26-044761 | 1873835 | Immix Biopharma, Inc. | IMMX | 2026-09-29 | 8-K | orphan | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1873835/000149315226044761/ex99-1.htm |
0001818794-26-000009 | 1818794 | Dyne Therapeutics, Inc. | DYN | 2026-09-29 | 8-K | topline | false | dyn-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1818794/000181879426000009/dyn-ex99_1.htm |
0001818794-26-000009 | 1818794 | Dyne Therapeutics, Inc. | DYN | 2026-09-29 | 8-K | orphan | false | dyn-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1818794/000181879426000009/dyn-ex99_1.htm |
0001453687-26-000105 | 1453687 | Cartesian Therapeutics, Inc. | RNAC | 2026-09-29 | 8-K | topline | false | pressrelease9292026.htm | https://www.sec.gov/Archives/edgar/data/1453687/000145368726000105/pressrelease9292026.htm |
0001453687-26-000105 | 1453687 | Cartesian Therapeutics, Inc. | RNAC | 2026-09-29 | 8-K | orphan | false | pressrelease9292026.htm | https://www.sec.gov/Archives/edgar/data/1453687/000145368726000105/pressrelease9292026.htm |
0001171843-26-006273 | 1677940 | BeyondSpring Inc. | BYSI | 2026-09-29 | 8-K | interim | false | exh_991.htm | https://www.sec.gov/Archives/edgar/data/1677940/000117184326006273/exh_991.htm |
0001171843-26-006273 | 1677940 | BeyondSpring Inc. | BYSI | 2026-09-29 | 8-K | clinical_hold | true | exh_101.htm | https://www.sec.gov/Archives/edgar/data/1677940/000117184326006273/exh_101.htm |
0001171843-26-006273 | 1677940 | BeyondSpring Inc. | BYSI | 2026-09-29 | 8-K | fast_track | false | exh_991.htm | https://www.sec.gov/Archives/edgar/data/1677940/000117184326006273/exh_991.htm |
0001171843-26-006273 | 1677940 | BeyondSpring Inc. | BYSI | 2026-09-29 | 8-K | ind | false | exh_11.htm | https://www.sec.gov/Archives/edgar/data/1677940/000117184326006273/exh_11.htm |
0001193125-26-405954 | 1341235 | Aldeyra Therapeutics, Inc. | ALDX | 2026-09-29 | 8-K | crl | true | aldx-20260929.htm | https://www.sec.gov/Archives/edgar/data/1341235/000119312526405954/aldx-20260929.htm |
0001193125-26-405954 | 1341235 | Aldeyra Therapeutics, Inc. | ALDX | 2026-09-29 | 8-K | fast_track | false | aldx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1341235/000119312526405954/aldx-ex99_1.htm |
0001193125-26-405954 | 1341235 | Aldeyra Therapeutics, Inc. | ALDX | 2026-09-29 | 8-K | orphan | false | aldx-ex99_1.pdf | https://www.sec.gov/Archives/edgar/data/1341235/000119312526405954/aldx-ex99_1.pdf |
0001193125-26-405954 | 1341235 | Aldeyra Therapeutics, Inc. | ALDX | 2026-09-29 | 8-K | pdufa | false | aldx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1341235/000119312526405954/aldx-ex99_1.htm |
0001193125-26-406036 | 1488039 | ATOSSA THERAPEUTICS, INC. | ATOS | 2026-09-29 | 8-K | orphan | false | atos-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1488039/000119312526406036/atos-ex99_1.htm |
0001193125-26-405580 | 1607678 | Viking Therapeutics, Inc. | VKTX | 2026-09-28 | 8-K | clinical_hold | true | vktx-ex1_1.htm | https://www.sec.gov/Archives/edgar/data/1607678/000119312526405580/vktx-ex1_1.htm |
0001193125-26-405580 | 1607678 | Viking Therapeutics, Inc. | VKTX | 2026-09-28 | 8-K | ind | false | vktx-ex1_1.htm | https://www.sec.gov/Archives/edgar/data/1607678/000119312526405580/vktx-ex1_1.htm |
0001178253-26-000037 | 1178253 | SCYNEXIS INC | SCYX | 2026-09-28 | 8-K | orphan | false | scyx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1178253/000117825326000037/scyx-ex99_1.htm |
0001129928-26-000057 | 1129928 | ONCOLYTICS BIOTECH INC | ONCY | 2026-09-28 | 8-K | fast_track | false | oncolyticsreo033trialmomen.htm | https://www.sec.gov/Archives/edgar/data/1129928/000112992826000057/oncolyticsreo033trialmomen.htm |
0001829126-26-010493 | 1979414 | NEONC TECHNOLOGIES HOLDINGS, INC. | NTHI | 2026-09-28 | 8-K | ind | false | neonctechnologies_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1979414/000182912626010493/neonctechnologies_ex99-1.htm |
0001759425-26-000049 | 1759425 | Mirum Pharmaceuticals, Inc. | MIRM | 2026-09-28 | 8-K | topline | false | mirm-20260925.htm | https://www.sec.gov/Archives/edgar/data/1759425/000175942526000049/mirm-20260925.htm |
0001759425-26-000049 | 1759425 | Mirum Pharmaceuticals, Inc. | MIRM | 2026-09-28 | 8-K | endpoint_met | false | mirm-20260925.htm | https://www.sec.gov/Archives/edgar/data/1759425/000175942526000049/mirm-20260925.htm |
0001193125-26-403481 | 1468748 | Kodiak Sciences Inc. | KOD | 2026-09-28 | 8-K | topline | false | d185059dex991.htm | https://www.sec.gov/Archives/edgar/data/1468748/000119312526403481/d185059dex991.htm |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.